These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 2568650

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cognitive sequelae of tardive dyskinesia.
    DeWolfe AS, Ryan JJ, Wolf ME.
    J Nerv Ment Dis; 1988 May; 176(5):270-4. PubMed ID: 2896762
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Negative symptoms as a risk factor for tardive dyskinesia in schizophrenia.
    Liddle PF, Barnes TR, Speller J, Kibel D.
    Br J Psychiatry; 1993 Dec; 163():776-80. PubMed ID: 7905774
    [Abstract] [Full Text] [Related]

  • 8. Effects of verapamil on tardive dyskinesia and psychosis in schizophrenic patients.
    Reiter S, Adler L, Angrist B, Peselow E, Rotrosen J.
    J Clin Psychiatry; 1989 Jan; 50(1):26-7. PubMed ID: 2562952
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tardive dyskinesia: neuropsychological, computerized tomographic, and psychiatric symptom findings.
    Gold JM, Egan MF, Kirch DG, Goldberg TE, Daniel DG, Bigelow LB, Wyatt RJ.
    Biol Psychiatry; 1991 Sep 15; 30(6):587-99. PubMed ID: 1681948
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Schizophrenic deficit syndrome and neurologic tolerance].
    Verdoux H, Bourgeois M.
    Encephale; 1996 Jun 15; 22 Spec No 2():45-7. PubMed ID: 8767042
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tardive dyskinesia and positive symptoms of schizophrenia.
    White T, Brown KW, Woods JP.
    Acta Psychiatr Scand; 1991 May 15; 83(5):377-9. PubMed ID: 1677232
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Withdrawal-emergent dyskinesia in patients with schizophrenia during antipsychotic discontinuation.
    Schultz SK, Miller DD, Arndt S, Ziebell S, Gupta S, Andreasen NC.
    Biol Psychiatry; 1995 Dec 01; 38(11):713-9. PubMed ID: 8580223
    [Abstract] [Full Text] [Related]

  • 17. Relation of neuroleptic dose and tardive dyskinesia to attention, information-processing, and psychophysiology in medicated schizophrenics.
    Spohn HE, Coyne L, Lacoursiere R, Mazur D, Hayes K.
    Arch Gen Psychiatry; 1985 Sep 01; 42(9):849-59. PubMed ID: 2864028
    [Abstract] [Full Text] [Related]

  • 18. The prediction of chronic persistent versus intermittent tardive dyskinesia. A retrospective follow-up study.
    Glazer WM, Morgenstern H, Doucette JT.
    Br J Psychiatry; 1991 Jun 01; 158():822-8. PubMed ID: 1678663
    [Abstract] [Full Text] [Related]

  • 19. [Psychopathology and cognitive disorders in chronic schizophrenic patients with tardive dyskinesia].
    Kaiser W.
    Nervenarzt; 1989 Apr 01; 60(4):206-12. PubMed ID: 2566936
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.